| Q3 2017 |
119 |
$262M |
+$5.89M |
-$8.73M |
-$2.84M |
ADBE, ALNY, SGMO, CMCSA, SBAC
|
13F-HR |
11/14/2017, 02:51 PM |
| Q2 2017 |
116 |
$243M |
+$13.6M |
-$9.73M |
+$3.86M |
ADBE, ALNY, CMCSA, SGMO, SBAC
|
13F-HR |
8/11/2017, 04:33 PM |
| Q1 2017 |
118 |
$226M |
+$28.8M |
-$12.5M |
+$16.4M |
ADBE, CMCSA, SBAC, ALNY, BRKB
|
13F-HR |
5/12/2017, 04:43 PM |
| Q4 2016 |
113 |
$199M |
+$9.33M |
-$28.5M |
-$19.2M |
ADBE, CMCSA, BRKB, ALNY, NXPI
|
13F-HR |
2/13/2017, 06:00 PM |
| Q3 2016 |
117 |
$223M |
+$13M |
-$10.9M |
+$2.14M |
ADBE, ALNY, SBAC, CMCSA, BRKB
|
13F-HR |
11/14/2016, 11:30 AM |
| Q2 2016 |
121 |
$210M |
+$13.4M |
-$9.25M |
+$4.17M |
ADBE, ALNY, CMCSA, SBAC, BRKB
|
13F-HR |
8/11/2016, 02:17 PM |
| Q1 2016 |
116 |
$207M |
+$12.8M |
-$22.3M |
-$9.57M |
ADBE, ALNY, CMCSA, SBAC, BRKB
|
13F-HR |
5/12/2016, 09:20 AM |
| Q4 2015 |
119 |
$226M |
+$22.1M |
-$23.1M |
-$974K |
ALNY, ADBE, CMCSA, SGMO, SBAC
|
13F-HR |
2/11/2016, 04:26 PM |
| Q3 2015 |
108 |
$213M |
+$25.6M |
-$25.6M |
-$38.5K |
ALNY, ADBE, CMCSA, CCG, CVA
|
13F-HR |
11/13/2015, 03:55 PM |
| Q2 2015 |
120 |
$252M |
+$10.1M |
-$16M |
-$5.88M |
ALNY, ADBE, SGMO, CVA, NRG
|
Restatement |
8/14/2015, 08:05 AM |
| Q1 2015 |
128 |
$263M |
+$18.8M |
-$14.3M |
+$4.59M |
ALNY, SGMO, ADBE, CVA, LAB
|
13F-HR |
5/12/2015, 10:42 AM |
| Q4 2014 |
129 |
$258M |
+$10.2M |
-$14.7M |
-$4.45M |
ALNY, SGMO, ADBE, CVA, INTC
|
13F-HR |
2/11/2015, 11:48 AM |
| Q3 2014 |
134 |
$250M |
+$18.7M |
-$18.5M |
+$173K |
ALNY, ADBE, SGMO, CVA, NRG
|
Restatement |
11/13/2014, 11:02 AM |
| Q2 2014 |
143 |
$257M |
+$25.9M |
-$25.3M |
+$631K |
SGMO, ADBE, ALNY, NRG, CVA
|
13F-HR |
8/12/2014, 02:58 PM |
| Q1 2014 |
139 |
$245M |
+$33.1M |
-$15.1M |
+$18M |
SGMO, ALNY, ADBE, NRG, CVA
|
13F-HR |
5/14/2014, 03:16 PM |
| Q4 2013 |
148 |
$223M |
$0 |
$0 |
|
SGMO, ADBE, ALNY, INTC, NRG
|
13F-HR |
2/12/2014, 10:15 AM |